ORKA R&D Expenses

Oruka Therapeutics Inc · R&D Expenses

ORKA logo

ORKA R&D Expenses

Latest reported$43.26M
ORKA Quarterly R&D Expenses ($3.25M → $43.26M)
High-resolution chart · PNG

ORKA r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Oruka Therapeutics Inc R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
43,257,000
29,145,000
27,640,000
28,988,000
24,087,000
19,925,000
32,326,630
25,691,000
18,673,000
165,000
47,000
322,000
254,000
390,000
266,000
534,000
995,000
2,179,000
3,941,000
3,438,000
3,577,000
2,876,000
3,204,000
1,051,000
372,000
365,000
384,000
347,000
440,000
662,000
625,000
740,000
1,154,000
1,720,000
2,834,000
3,488,000
4,508,000
3,246,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.